Human immunodeficiency virus type 1 NL4-3 replication in four T-cell lines: rate and efficiency of entry, a major determinant of permissiveness. 1991

K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
Department of Pathology, University of Massachusetts Medical Center, Worcester 01655.

Single-cycle infections have been used to study the human immunodeficiency virus type 1 (HIV-1) life cycle in CD4+ T-cell lines that differ in their permissiveness for infection. In single-cycle infections of highly permissive C8166 cells, 50% of the infectious units escaped being blocked by a monoclonal antibody against the virus binding site on CD4 (leu3a) within 30 min. In contrast, 50% of the infectious units for three less permissive cell lines (H9, A3.01, and Jurkat) required 4 h to escape the leu3a block. Entry was also more efficient in the highly permissive cells, with NL4-3 stocks having three times more infectious units for C8166 cells than for H9, A3.01, or Jurkat cells. Postentry steps up through reverse transcription required approximately 3.5 h in each of the cell lines. The times lapsing between reverse transcription and the expression of reverse transcripts ranged from 17 to 25 h in the different cell lines. Virus production per cell was also similar in the different cell lines (within 1.5-fold of each other). These results indicate that a major determinant of the permissiveness of growing T cells for HIV-1 is the rate and efficiency of virus entry.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
August 2017, Virus research,
K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
October 2004, Journal of virology,
K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
July 2006, International journal of hematology,
K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
November 1989, Virus genes,
K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
February 2003, Journal of virology,
K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
September 1995, Proceedings of the National Academy of Sciences of the United States of America,
K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
January 2009, Journal of virology,
K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
January 1997, AIDS research and human retroviruses,
K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
December 2007, Vaccine,
K K Srivastava, and R Fernandez-Larsson, and D M Zinkus, and H L Robinson
July 1996, Journal of virology,
Copied contents to your clipboard!